These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 7951120
1. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia. Kantarjian HM, Talpaz M, Andersson B, Khouri I, Giralt S, Rios MB, Champlin R, Hester J, Deisseroth AB. Bone Marrow Transplant; 1994 Jul; 14(1):57-61. PubMed ID: 7951120 [Abstract] [Full Text] [Related]
2. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F. Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [Abstract] [Full Text] [Related]
3. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL. Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008 [Abstract] [Full Text] [Related]
4. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G. Haematologica; 1997 Nov; 82(3):291-6. PubMed ID: 9234574 [Abstract] [Full Text] [Related]
5. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients. Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Kabisch H, Jaburg N, Löliger C, Krüll A, Zander AR. Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663 [Abstract] [Full Text] [Related]
6. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Kröger N, Krüger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschläder M, Fuchs N, Rüssmann B, Renges H, Dürken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander AR. Bone Marrow Transplant; 1998 Dec; 22(11):1029-33. PubMed ID: 9877263 [Abstract] [Full Text] [Related]
7. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation. Jabro G, Koc Y, Boyle T, Schenkein DP, Ravalese J, Wazer D, Miller KB. Biol Blood Marrow Transplant; 1999 Dec; 5(3):173-9. PubMed ID: 10392963 [Abstract] [Full Text] [Related]
8. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides]. Sun J, Wu B, Liu Q, Feng R, Liu X, Meng F, Zhou S. Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009 [Abstract] [Full Text] [Related]
9. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia]. Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY. Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032 [Abstract] [Full Text] [Related]
10. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300 [Abstract] [Full Text] [Related]
11. Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience. Koziner B, Dengra C, Lucero G, Klein G, Cánepa C, Milovic V, Milone G, Robinson A, Cerutti I, Saporito G, Kusminsky G, Milone J, Bordone J, Lastiri F, Argentine Group of Bone Marrow Transplantation. Cancer; 2002 Dec 01; 95(11):2339-45. PubMed ID: 12436440 [Abstract] [Full Text] [Related]
12. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia. Kantarjian HM, Talpaz M, LeMaistre CF, Spinolo J, Spitzer G, Yau J, Dicke K, Jagannath S, Deisseroth AB. Cancer; 1991 Jun 15; 67(12):2959-65. PubMed ID: 1675151 [Abstract] [Full Text] [Related]
13. Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion. Carella AM, Podestà M, Frassoni F, Pungolino E, Pollicardo N, Raffo MR, Ferrero R, Benvenuto F, Figari O, Giordano D. Stem Cells; 1993 Oct 15; 11 Suppl 3():67-72. PubMed ID: 7905325 [Abstract] [Full Text] [Related]
14. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome]. Meng FY, Sun J, Liu QF, Xu D, Yang LJ, Song LL, Liu XL, Xu B, Zhou SY. Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec 15; 23(12):1301-2, 1306. PubMed ID: 14678896 [Abstract] [Full Text] [Related]
15. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C. Bone Marrow Transplant; 1993 Sep 15; 12(3):267-71. PubMed ID: 7694724 [Abstract] [Full Text] [Related]
16. Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia. Horwitz LJ, Kantarjian HM, Jagannath S, Keating MJ, McCredie KB, Spitzer G, Vellekoop L, Zander AR, Dicke KA. Bone Marrow Transplant; 1989 Jan 15; 4(1):101-5. PubMed ID: 2647172 [Abstract] [Full Text] [Related]
17. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex. Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL. Bone Marrow Transplant; 1999 Nov 15; 24(10):1057-63. PubMed ID: 10578155 [Abstract] [Full Text] [Related]
18. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Cottafavi L, Dotti GP, Rizzoli V. Bone Marrow Transplant; 1994 Sep 15; 14(3):425-32. PubMed ID: 7994267 [Abstract] [Full Text] [Related]
19. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia]. Hatsuse M, Okano A, Okamoto A, Shimura K, Takahashi R, Hirai H, Ashihara E, Inaba T, Fujita N, Shimazaki C, Nakagawa M. Rinsho Ketsueki; 2000 Aug 15; 41(8):671-5. PubMed ID: 11020996 [Abstract] [Full Text] [Related]
20. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization. Olavarria E, Parker S, Craddock C, Philpott N, Tiniakou M, Chase A, Kanfer E, Apperley JF, Goldman JM. Haematologica; 2000 Jun 15; 85(6):647-52. PubMed ID: 10870123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]